Please assess the completion status of the following clinical trial:

Trial Title: Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* DSM-IV criteria for bipolar I (manic or mixed) or mania for at least 4 weeks~* CGAS less than or equal to 60~* Good physical health~Exclusion Criteria:~* Schizophrenia or any pervasive developmental disorder~* Major medical or neurological disease~* History of addiction to illicit substances or alcohol or drug abuse within the last 4 weeks~* IQ less than 70~* Pregnancy or breast-feeding~* Unacceptable methods of contraception~* In-patient care at baseline

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Participants will receive treatment with lithium for 8 to 16 weeks
- 2 (Type: EXPERIMENTAL): Participants will receive treatment with valproate for 8 to 16 weeks
- 3 (Type: EXPERIMENTAL): Participants will receive treatment with risperidone for 8 to 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).